MRI in Radiation Therapy

Peer-to-peer exchange of protocols, articles and tips

MRI in Radiation Therapy
 
Contacte-nos

Following the rapid adoption of MRI in radiation therapy, Siemens Healthineers has developed tailored solutions that also address those departments that have traditionally used CT imaging alone. On these pages of the MAGNETOM World we aim to increase peer-to-peer exchange of practices and to demonstrate how MAGNETOM users around the world are tackling the challenges posed by the introduction of MRI in the radiotherapy routine.


Articles

Editorial Comment: MRI and cancer radiotherapy

Paul Keall, University of Sydney, Australia

 

Replacement of a CT-simulator with an MRI-simulator within a radiation oncology department

Peter Greer et al., Calvary Mater Newcastle, Newcastle, Australia

 

MRI for prostate and gynecological brachytherapy is here to stay

Firas Mourtada, Ph.D. et al., Helen F. Graham Cancer Center & Research Institute, Newark, USA

 

MR-only guided proton therapy: advances, future perspectives and challenges

R.J.H. Borra, M.D., Ph.D. et al., University Medical Center Groningen, Groningen, The Netherlands

 

MR-simulation for radiotherapy treatment planning of head and neck cancer using 3T MAGNETOM Vida

Daniela Thorwarth et al., University of Tübingen, Germany

  

Dynamic 2D magnetic resonance imaging for assessment of larynx motion in early glottic cancer radiotherapy

Houda Bahig, M.D. et al., Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada

 

Improved therapy response assessment in metastatic brain tumors

Kyrre Eeg Emblem, Ph.D. et al., Oslo University Hospital, Oslo, Norway

 

Spectroscopic MRI for dose-escalated radiation therapy

Hyunsuk Shim, Ph.D. et al., Winship Cancer Institute of Emory University, Atlanta, GA, USA

 

MyoMap quantification of myocardial toxicity following concurrent chemoradiotherapy for esophageal carcinoma

Gary Liney et al., Liverpool Cancer Therapy Centre, Sydney, Australia

 

First experience of 4D-MRI for abdominal radiotherapy planning

Andrew Oar et al., Liverpool and Macarthur Cancer Therapy Centre, Sydney, Australia

 

Quantitative WB-MRI with ADC histogram analysis for response assessment in diffuse bone disease

Anwar R. Padhani et al., Paul Strickland Scanner Centre, Northwood, Middlesex, United Kingdom

 

Diffusion and perfusion MR parameters to assess preoperative short course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among parameters derived from standardized index of shape DCE-MRI, intravoxel incoherent motion and diffusion kurtosis imaging

Biagio Pecori et al., Istituto Nazionale Tumori (IRCCS), Fondazione G. Pascale, Naples, Italy

 

Editorial Comment: MRI in Radiation Therapy

David A. Jaffray, Princess Margaret Cancer Centre, Toronto, Canada

 

4D-MRI Sequence for Radiotherapy Application: Validation of a Retrospective Method on a Motion Phantom

Soléakhéna Ken, Ph.D. et al., Institut Universitaire du Cancer de Toulouse Oncopôle, Toulouse, France

 

MRI in Head and Neck Radiotherapy Planning

Houda Bahig, M.D. et al., Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada

 

Optimizing Fiducial Markers for MRI-based Radiotherapy

Ingemar Näslund, M.D., Ph.D. et al., Karolinska Institutet, Stockholm, Sweden

 

Performing Gynecologic Brachytherapy in the Medical Innovation Technical Expert Center

Lia Verhoef et al., Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, Netherlands

 

Early Measures of Perfusion and Diffusion Changes Using a Standardized Analysis Platform Evaluated in Brain Metastases Treated with Stereotactic Radiosurgery

Catherine Coolens, Ph.D. et al., Princess Margaret Cancer Centre and University Health Network, University of Toronto, Toronto, ON, Canada

 

Integration of Diffusion-Weighted Imaging / Diffusion Tensor Imaging into Radiation Therapy Treatment Planning of Brain Tumors

Tong Zhu, Ph.D. et al., University of North Carolina at Chapel Hill, NC, USA

 

Initial Clinical Experience Utilizing 4D-MRI for Radiation Treatment Planning

Eric S. Paulson, Ph.D., DABR et al., Medical College of Wisconsin, Milwaukee, WI, USA

 

Metastatic Prostate Cancer in Practice – the MET-RADS-P Imaging Response System Using Whole-body MRI

Prof. Anwar R. Padhani, MB, BS, FRCP, FRCR et al., Paul Strickland Scanner Centre, Northwood, Middlesex, UK

 

Observing Endocrine Therapy Resistance in Metastatic Breast Cancer with Whole-body MRI

Anwar R. Padhani et al., Paul Strickland Scanner Centre, Northwood, Middlesex, UK

 

Whole-body Diffusion-weighted MR Image Analysis with syngo.via Frontier MR Total Tumor Load

Robert Grimm, Ph.D. et al., Siemens Healthineers, Erlangen, Germany

 

Whole-body MR Image Reading and Bone Assessment with syngo.via Frontier MR Bone Scan

Matthias Fenchel, Ph.D. et al., Siemens Healthineers, Erlangen, Germany

 

Magnet Homogeneity and Shimming

Mathias Blasche, MS et al., Siemens Healthineers, Erlangen, Germany

 

Radiotherapy Planning Using MRI

Maria A. Schmidt, Ph.D. et al., Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK

 

Benefits of Time-Correlated and Breath-Triggered MR

Soléakhéna Ken, Ph.D. et al.,  Institut Universitaire du Cancer de Toulouse Oncopôle, Toulouse, France

 

Comprehensive RT-Specific QA for MRI Simulation

Eric Paulson, Ph.D., DABR, Medical College of Wisconsin, Milwaukee, WI, USA

 

Management of MRI Spatial Accuracy for Radiation Therapy

Teo Stanescu, PhD et al., Princess Margaret Cancer Centre, Toronto, ON, Canada

 

MRI in Clinical Radiation Oncology: Dosimetry and Patient-Specific Plan Verification

Niko Papanikolaou, Ph.D. et al., University of Texas Health Science Center, San Antonio, Texas, USA

 

MR-guided Gynecological High Dose Rate (HDR) Brachytherapy

Joann I. Prisciandaro, Ph.D. et al., University of Michigan, Ann Arbor, MI, USA

 

Multi-parametric MRI at 3 Tesla for Prediction of Treatment Response in Rectal Cancer

Dr. Trang Pham et al., Liverpool Cancer Therapy Centre, Sydney, Australia

 

Significant Benefit of Optimized 3D SPACE Sequences in Radiation Therapy Treatment

Maja Sohlin, Ph.D. et al., Sahlgrenska University Hospital, Gothenburg, Sweden

 

The Potential Role of Ultrashort Echo Time Sequences in MRI Guided Radiotherapy

Gary Liney et al., Liverpool Cancer Therapy Centre, Liverpool Hospital, Sydney, Australia

 

4D-MRI: Future of Radiotherapy of Moving Targets?

Antony John Lomax et al., Center for Proton Therapy (CPT), Paul Scherrer Institut, Villigen PSI, Switzerland

 

Development of MR-only Planning for Prostate Radiation Therapy Using Synthetic CT

Peter Greer, Ph.D. et al., Calvary Mater Newcastle, Newcastle, New South Wales, Australia

 

RT Dot Engine

Gregor Thörmer, Ph.D. et al., Siemens Healthineers, Erlangen, Germany

 

Anatomical and Functional MRI for Radiotherapy Planning of Head and Neck Cancers

Maria A. Schmidt, Ph.D. et al., Cancer Imaging Centre, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK

 

syngo.via RT Image Suite: Empower Radiation Therapy with MRI Information

Elena Nioutsikou, Siemens Healthineers, Forchheim, Germany

 

Technical Aspects of MR-only Radiotherapy

Tufve Nyholm et al., Umeå University, Sweden

 

A Dedicated MRI Scanner for Radiotherapy Planning: Early Experiences

Gary Liney, Liverpool Cancer Therapy Centre, Liverpool Hospital, Sydney, Australia

 

MR-guided Gynecological High Dose Rate (HDR) Brachytherapy

Joann I. Prisciandaro, Ph.D. et al., Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA

 

Clinical Application of Diffusion Tensor Imaging in Radiation Planning for Brain Tumors

Jatta Berberat, Ph.D. et al., Radiation Oncology, Canton Hospital, Aarau, Switzerland

 

Optimizing MRI for Radiation Oncology: Initial Investigations

James M. Balter, Ph.D., FAAPM et al., Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA

 

Case Report: Functional, Volumetric, Treatment Response Assessment Using MR OncoTreat

Ihab R. Kamel, M.D., Ph.D. et al., The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins Hospital, Baltimore, MD, USA

 

1The products/features shown on this webpage are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

2syngo.via VB10 and the syngo.via VB10 based software options are currently under development, and not for sale in the U.S., China and other countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

3syngo.via VB10 and the syngo.via based software options are currently under development; not for sale in the U.S. and other countries. Future availability cannot be guaranteed.

The herein illustrated statements made by Siemens’ customers and physicians are based on their own and discrete opinion and do not reflect Siemens' opinion. Siemens dissociates from the content and Siemens does not intend to promote the content of the statement as true, state of the art or as Siemens opinion. The Siemens' customers and physicians have not made these statements due to any financial support or contribution by Siemens or due to any other contractual obligation. The distribution of these statements by Siemens shall only illustrate the variety of different opinions and approaches regarding MR technology.